Drugs / Diphtheria, tetanus, pertussis, hepatitis B, Hib vaccine
Diphtheria, tetanus, pertussis, hepatitis B, Hib vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00316680 | Mar → Nov 2006 | diphtheria, haemophilus infectious disease, hepatitis B virus infection, tetanus | GlaxoSmithKline | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Diphtheria, tetanus, pertussis, hepatitis B, Hib vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00316680 ↗ |
| Modality | Vaccine | “a vaccine” NCT00316680 ↗ |